Dianthus Therapeutics, Inc. /DE/ ($DNTH)
Filing Information
| Accession Number | 0001669866-26-000010 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 7, 2026 |
| Document | View SEC Filing |
Transactions
11
Total Shares
498,000
Total Value
$19,346,491.37
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 7, 2026 | Exercise/Conversion | 40,000 | $8.44 | $337,600.00 | 105,292 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 7, 2026 | Exercise/Conversion | 126,000 | $8.44 | $1,063,440.00 | 231,292 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 7, 2026 | Sale | 10,384 | $107.49 | $1,116,176.16 | 220,908 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 7, 2026 | Sale | 23,907 | $108.05 | $2,583,151.35 | 197,001 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 7, 2026 | Sale | 2,373 | $109.10 | $258,894.30 | 194,628 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 7, 2026 | Sale | 2,536 | $110.02 | $279,010.72 | 192,092 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 7, 2026 | Sale | 800 | $110.76 | $88,608.00 | 191,292 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 7, 2026 | Sale | 104,091 | $107.96 | $11,237,664.36 | 87,102 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 7, 2026 | Sale | 21,909 | $108.72 | $2,381,946.48 | 65,292 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Aug 7, 2026 | Exercise/Conversion | 40,000 | $0.00 | $0.00 | 286,004 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Aug 7, 2026 | Exercise/Conversion | 126,000 | $0.00 | $0.00 | 160,004 | Direct | โ | View Details |